[1] Mitoma H,Adhikari K,Aeschlimann D,et al.Consensus paper: neuroimmune mechanisms of cerebellar ataxias[J].Cerebellum, 2016,15(2):213-232.
[2] Mitoma H,Manto M,Hampe C S.Immune-mediated cerebellar ataxias: practical guidelines and therapeutic challenges[J].Curr Neuropharmacol,2019,17(1):33-58.
[3] 刘曼歌,关鸿志,任海涛.抗体相关自身免疫性小脑性共济失调的诊疗进展[J].中华神经科杂志,2021,54(8):857-861.
[4] Hadjivassiliou M,Boscolo S,Tongiorgi E,et al.Cerebellar ataxia as a possible organ-specific autoimmune disease[J].Mov Disord,2008,23(10):1370-1377.
[5] Han F,Ren H,Tang M,et al.Clinical reasoning: a 47-year-old man with rapidly progressive ataxia and vitiligo[J]. Neurology,2020,94(15):e1664-e1669.
[6] 张奇山,黄仁彬,廖远高,等.原发性自身免疫性小脑共济失调一例[J].中华神经科杂志, 2016,49(1):67-68.
[7] 熊李,丁卫江,漆学良.原发性自身免疫性小脑共济失调2例[J].广东医学,2017,38(9):1467.
[8] Hadjivassiliou M,Martindale J,Shanmugarajah P,et al.Causes of progressive cerebellar ataxia: prospective evaluation of 1500 patients[J].J Neurol Neurosurg Psychiatry,2017,88(4):301-309.
[9] Liu M G,Ren H T,Zhu Y C,et al.Autoimmune cerebellar ataxia: etiology and clinical characteristics of a case series from china[J].Cerebellum,2023,22(3):379-385.
[10] Hadjivassiliou M,Graus F,Honnorat J,et al.Diagnostic criteria for primary autoimmune cerebellar ataxia (PACA) - guidelines from an international task force on immune mediated cerebellar ataxia[J].Cerebellum, 2020,19(4):605-610.
[11] 中华医学会神经病学分会感染性疾病与脑脊液细胞系学组.自身免疫性小脑共济失调诊断专家共识[J]. 中华神经科杂志,2024, 57(8):830-839.
[12] Joubert B, Honnorat J.Nonparaneoplastic autoimmune cerebellar ataxias[J]. Curr Opin Neurol, 2019, 32(3): 484-492.
[13] 马智慧,李雪雁,张梅,等.环肽cGY-8对小鼠急性缺氧脑损伤的保护作用及转录组学分析[J].空军军医大学学报,2024,45(12):1412-1419.
[14] 贾俊丽,徐广润,孔文程.抗Homer3抗体阳性自身免疫性小脑共济失调1例并文献复习[J].中华神经科杂志, 2022,55(22):1407-1412.
[15] SchmitzH T,Tezenas M S,Baliko L,et al.Scale for the assessment and rating of ataxia: development of a new clinical scale[J].Neurology,2006,66(11):1717-1720.
[16] Trouillas P,Takayanagi T,Hallett M,et al.International cooperative ataxia rating scale for pharmacological assessment of the cerebellar syndrome. The ataxia neuropharmacology committee of the world federation of neurology[J].J Neurol Sci,1997,145(2):205-211.
[17] Mitoma H,Adhikari K,Aeschlimann D,et al.Consensus paper:neuroimmune mechanisms of cerebellar ataxias[J].Cerebellum,2016,15(2):213-232.
[18] Mitoma H,Hadjivassiliou M,Honnorat J.Guidelines for treatment of immune-mediated cerebellar ataxias[J]. Cerebellum Ataxias,2015,10(2):14.
[19] Zhang W H,Ren H T,Fang F,et al.Neurochondrin antibody serum positivity in three cases of autoimmune cerebellar ataxia[J].Cerebellum,2019,18(6):1137-1142.
[20] Xu X,Ren H,Li L,et al.Anti-homer-3 antibody associated cerebellar ataxia: a rare case report and literature review[J].J Neuroimmunol,2019,330(15):155-158.
[21] 秦天,苟小元,谭嘉懿,等.高压氧对高原脱习服小鼠脑组织病理损伤及能量代谢的影响[J].空军军医大学学报,2025,46(1):94-99.
[22] Hadjivassiliou M,Grunewald R A,Shanmugarajah P D,et al.Treatment of primary autoimmune cerebellar ataxia with mycophenolate[J].Cerebellum,2020,19(5):680-684.
[23] 关鸿志. 自身免疫性小脑共济失调的诊治[J].中华神经科杂志,2024,57(6):642-648.
[24] 中华医学会神经病学分会神经感染性疾病与脑脊液细胞学学组.中国自身免疫性脑炎诊治专家共识(2022年版)[J].中华神经科杂志,2022,55(9):931-949.
[25] Hiroshi M,Mario M,HadjivassiliouM.Immune-mediated cerebellar ataxias: clinical diagnosis and treatment based on immunological and physiological mechanisms[J].J Mov Disord,2021,14(1):10-28.
[26] Smets I,Titulaer M.Antibody therapies in autoimmune encephalitis[J].Neurotherapeutics,2022,19(3):823-831.
[27] 王晨,袁名扬,侯德仁.原发性自身免疫性小脑性共济失调的临床分析[J].国际神经病学神经外科学杂志. 2023,50(1):25-28.
[28] Liu M G,Ren H T,Wang L,et al.Prognostic and relapsing factors of primary antoimmune cerebellar ataxia:a prospective cohort study[J].J Neurology,2023,12(271):1072-1079.
[29] 刘曼歌, 任海涛, 关鸿志, 等. 抗体阳性的原发性自身免疫性小脑共济失调患者的临床特征[J]. 中华神经科杂志, 2025, 58(1): 55-63.
[30] Zhang W, Ren H,Ren X,et al.Autoimmune cerebellar ataxia associated with anti-Purkinje cells antibodies: the next frontier of neuroimmunology[J].Ann Transl Med,2023,11(7):285.